Search the Newsreel

Cryoport (Nasdaq:CYRX) - Stock Analysis

Cryoport (Nasdaq:CYRX) provides temperature-controlled supply chain solutions for biopharma, animal health, and reproductive medicine. The company has a market cap of US$766.3m, with analysts largely agreeing the stock price will rise by 26.8%, though it is currently unprofitable and facing significant insider selling. Recent …

Morgan Stanley (CYRX) updates Cryoport stake to about 4.5% in 13G/A filing

Morgan Stanley and its affiliate, Morgan Stanley Capital Services LLC, have reduced their stake in Cryoport, Inc. (CYRX) to below 5%, as detailed in a recent 13G/A SEC filing. Morgan Stanley now reports shared voting power over approximately 2.19 million shares and dispositive power …

CryoPort Inc (CYRX) President and CEO Jerrell Shelton Sells 28,800 Shares

CryoPort Inc's President and CEO, Jerrell Shelton, sold 28,800 shares of CYRX for approximately $429,408. This transaction is part of a larger trend of insider selling at the company, with no insider purchases in the last year, suggesting insiders might view the stock as …

Cryoport president, CEO Shelton sells $429k in stock via 10b5-1 plan

Cryoport's President and CEO, Jerrell Shelton, sold 28,800 shares of the company's common stock for approximately $429,384 on August 11, 2026, through a pre-arranged 10b5-1 trading plan. This sale occurred as Cryoport's shares have seen significant growth, up 76% over the past year. The …

Cryoport (NASDAQ: CYRX) plans sale of 28,800 common shares

Cryoport, Inc. has filed a Form 144 disclosing a planned sale of up to 28,800 common shares on NASDAQ, with an aggregate value of $426,816.00. The shares, originating from restricted stock units and previously exercised holdings acquired on February 29, 2012, are intended to …

Assenagon Asset Management S.A. Has $18.09 Million Holdings in CryoPort, Inc. $CYRX

Assenagon Asset Management S.A. reduced its stake in CryoPort, Inc. (NASDAQ:CYRX) by 23% in the second quarter, now holding 1.15 million shares valued at $18.09 million. Despite this, institutional investors collectively own 92.9% of the company, and analysts maintain a "Moderate Buy" consensus with …

CryoPort, Inc. Stock 12‑Month Price Target Raised to $19.33, Implies 31% Upside

CryoPort, Inc.'s stock price target has been increased to $19.33 by analysts, up from $17.06, with a potential upside of 31% based on the recent closing price. The consensus rating from 9 analysts remains "Buy," with 8 recommending a Buy and 1 a Hold.

Cryoport, Inc. (CYRX) stock price, news, quote and history

This article provides comprehensive financial information for Cryoport, Inc. (CYRX), including its stock price, news, and historical data. It details the company's overview, its services in temperature-controlled supply chain solutions for the life sciences industry, and its recent performance metrics, analyst ratings, and financial …

Cryoport Inc (CYRX) Stock News Today

CryoPort (NASDAQ:CYRX) Releases Earnings Results, Misses Expectations By $0.01 EPS

Cryoport affirms $192M-$196M 2026 revenue guidance while targeting continued adjusted EBITDA expansion

Earnings Call Insights: Cryoport, Inc. (CYRX) Q2 2026 MANAGEMENT VIEW * "We're pleased to report that our revenue momentum over the past several periods continued into the second quarter, with our total revenue reaching $49 million," said (Chairman, President & CEO Jerrell Shelton), while …

Cryoport Releases Q2 2026 Financial Results

Cryoport, Inc. announced its Q2 2026 financial results, reporting a loss per share of $0.20, matching analyst estimates, with a net loss of $8.3 million on revenues of $49.0 million. Revenue increased by 8.0% year-over-year, driven by its Life Sciences Services segment, which grew …

Cryoport, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CYRX) 2026-08-06

Cryoport (NASDAQ:CYRX) Reports In-Line Q2 Results as Stock Edges Higher

Cryoport (NASDAQ:CYRX) reported Q2 2026 results that were largely in line with analyst expectations, with revenue of $48.97 million against a consensus of $49.17 million and non-GAAP EPS of -$0.20 versus an expected -$0.1977. The stock reacted positively, moving about 1.3% higher in after-hours …

Cryoport, Inc. 1Q 2026: Revenue $48.97M, EPS ($0.2) — 10-Q Summary

Cryoport, Inc. reported its first-quarter 2026 results, showing a revenue increase to $48.97 million, but recorded a net loss and a diluted loss per share of ($0.2) compared to a profit in the prior year. Revenue growth was primarily driven by its Life Sciences …

Earnings call transcript: Cryoport posts q2 2026 profit milestone, shares rise after hours

Cryoport Inc earnings missed by $0.01, revenue topped estimates

Cryoport Inc (NASDAQ: CYRX) reported Q2 EPS of $-0.20, missing analyst estimates by $0.01, but its revenue of $48.97 million topped the consensus estimate of $48.21 million. The company's stock price has shown strong performance, up 7.94% in the last 3 months and 79.02% …

Earnings Flash (CYRX) Cryoport, Inc. Reports Q2 Revenue $49.0M, vs. FactSet Est of $48.2M

Cryoport, Inc. (CYRX) reported Q2 revenue of $49.0 million, surpassing FactSet's estimate of $48.2 million. The company, a provider of integrated, temperature-controlled supply chain solutions for life sciences, held its Q2 2026 Earnings Call on August 6, 2026. This financial update indicates a positive …

CRYOPORT ($CYRX) Releases Q2 2026 Earnings, Stock Rises

(CYRX) Price Dynamics and Execution-Aware Positioning

This article provides an in-depth analysis of Cryoport Inc. (NASDAQ: CYRX) price dynamics, highlighting a divergent sentiment across different time horizons and suggesting choppy market conditions. It outlines three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—each tailored to specific risk profiles and …

CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates

CryoPort, Inc. Revenue Breakdown – NASDAQ:CYRX

CryoPort, Inc. (NASDAQ: CYRX) generated $176.18 million USD in revenue last year, with its Life Sciences Services segment contributing the most at $101.03 million USD. The Americas region was the primary revenue source, accounting for $131.26 million USD. This indicates the company's strong performance …

CryoPort, Inc. Revenue Breakdown – DUS:CKX

CryoPort, Inc. (DUS:CKX) generated 150.00 million EUR in revenue last year, with its Life Sciences Services segment being the top performer, contributing 86.02 million EUR. The Americas region was the largest contributor to the company's revenue, accounting for 111.76 million EUR. This data provides …

CryoPort (CYRX) Expected to Announce Earnings on Thursday

CryoPort Number of Employees 2026 | Employee Count & Headcount Data

CryoPort, Inc. (NASDAQ: CYRX) has 749 employees as of March 2026, representing a 9.3% increase since 2023. The company is actively hiring, with 50 job postings in 2026, though hiring velocity has slightly decreased. The workforce is primarily based in the United States, and …

Cryoport (CYRX) gets 13G/A update on Millennium-linked 3.4% stake

Cryoport (CYRX) received a Schedule 13G/A filing update revealing that Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander collectively reported beneficial ownership in the company's common stock. Integrated Core Strategies reported a 3.1% stake, while the …

Empire Financial Management Company LLC Acquires 98,714 Shares of CryoPort, Inc. $CYRX

Empire Financial Management Company LLC increased its stake in CryoPort, Inc. (NASDAQ:CYRX) by 24.4% in the first quarter, now owning 502,575 shares valued at $4,161,000. Other hedge funds also adjusted their positions, with institutional investors collectively owning 92.90% of the company's stock. CryoPort reported …

Cryoport Inc (CYRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Cryoport Inc (CYRX), detailing its current price momentum, support and resistance levels, and insights from various technical indicators and moving averages. As of July 28, 2026, the stock is trading between resistance at $16.50 and support at …

Cryoport Inc (CYRX) Institutional Confidence

Cryoport Inc (CYRX) has an institutional shareholding score of 10.00, placing it first in its industry. The latest institutional shareholding proportion is 97.68%, a slight decrease from the previous quarter. First Eagle Investment is the largest institutional shareholder, holding 1.48% of outstanding shares.

CYRX|Cryoport Inc|Price:15.140|Chg%:-0.230

This article provides a detailed analysis of Cryoport Inc (CYRX) stock, including real-time quotes, key financial figures, and market trends. It highlights the company's strong fundamentals, high growth potential, and a "Buy" rating from analysts with a target price of $15.30. The content also …

Cryoport Inc (CYRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Cryoport Inc (CYRX) based on business segments and geographical regions. For the most recent fiscal year, Life Science products and BioLogistics solutions contributed almost equally to the majority of the company's revenue, with BioStorage/Bioservices making up a …

Cryoport Inc (CYRX) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Cryoport Inc (CYRX), indicating a current earnings forecast score of 8.60 and a ranking of 7 out of 75 in the Freight & Logistics Services industry. Analysts have set an average price target of $13.00, with a …

Cryoport Inc (CYRX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Cryoport Inc's (CYRX) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years, indicating no recent dividend payouts. The article presents a table for dividend data, though it …